Piper Jaffray analyst Matt O’Brien kept his Overweight rating and $300 price target on Align Technology after its announced settlement agreement with Straumann Group on a patent dispute going on for multiple years. The analyst sees the development as a positive for Align Technology as it removes the litigation expense and also allows the company to “tap into Straumann’s significant distribution in Europe.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.